Compare NBTX & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | STAA |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 867.9M |
| IPO Year | 2018 | 1995 |
| Metric | NBTX | STAA |
|---|---|---|
| Price | $49.33 | $32.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $36.00 | $22.81 |
| AVG Volume (30 Days) | 71.3K | ★ 861.8K |
| Earning Date | 03-31-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $58.17 | $30.82 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | ★ N/A | $321.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.64 | $15.59 |
| 52 Week High | $57.14 | $35.87 |
| Indicator | NBTX | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 62.43 | 79.35 |
| Support Level | $19.22 | $23.75 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 3.37 | 1.51 |
| MACD | 1.29 | 0.37 |
| Stochastic Oscillator | 70.98 | 66.34 |
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.